nodes	percent_of_prediction	percent_of_DWPC	metapath
Duloxetine—Protriptyline—Cyproheptadine—allergic rhinitis	0.262	0.637	CrCrCtD
Duloxetine—HTR6—Cyproheptadine—allergic rhinitis	0.116	0.273	CbGbCtD
Duloxetine—Naftifine—Diphenhydramine—allergic rhinitis	0.0919	0.223	CrCrCtD
Duloxetine—HTR2C—Cyproheptadine—allergic rhinitis	0.0672	0.159	CbGbCtD
Duloxetine—SLC6A2—Cyproheptadine—allergic rhinitis	0.0672	0.159	CbGbCtD
Duloxetine—HTR2A—Cyproheptadine—allergic rhinitis	0.0606	0.143	CbGbCtD
Duloxetine—Atomoxetine—Diphenhydramine—allergic rhinitis	0.0577	0.14	CrCrCtD
Duloxetine—CYP1A2—Desloratadine—allergic rhinitis	0.0323	0.0761	CbGbCtD
Duloxetine—CYP2D6—Desloratadine—allergic rhinitis	0.0266	0.0627	CbGbCtD
Duloxetine—CYP1A2—Diphenhydramine—allergic rhinitis	0.0185	0.0437	CbGbCtD
Duloxetine—CYP2D6—Loratadine—allergic rhinitis	0.0153	0.036	CbGbCtD
Duloxetine—CYP2D6—Diphenhydramine—allergic rhinitis	0.0153	0.036	CbGbCtD
Duloxetine—CYP2D6—Dexamethasone—allergic rhinitis	0.00528	0.0125	CbGbCtD
Duloxetine—NPY1R—G alpha (i) signalling events—PTGDR2—allergic rhinitis	8.37e-05	0.0429	CbGpPWpGaD
Duloxetine—NPY1R—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	7.77e-05	0.0398	CbGpPWpGaD
Duloxetine—NPY1R—Peptide ligand-binding receptors—CCL11—allergic rhinitis	7.52e-05	0.0385	CbGpPWpGaD
Duloxetine—NPY1R—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	6.65e-05	0.0341	CbGpPWpGaD
Duloxetine—Dermatitis—Montelukast—allergic rhinitis	6.61e-05	0.000408	CcSEcCtD
Duloxetine—Ill-defined disorder—Prednisolone—allergic rhinitis	6.6e-05	0.000407	CcSEcCtD
Duloxetine—Headache—Montelukast—allergic rhinitis	6.57e-05	0.000405	CcSEcCtD
Duloxetine—Visual impairment—Betamethasone—allergic rhinitis	6.57e-05	0.000405	CcSEcCtD
Duloxetine—Visual impairment—Dexamethasone—allergic rhinitis	6.57e-05	0.000405	CcSEcCtD
Duloxetine—Mental disorder—Methylprednisolone—allergic rhinitis	6.56e-05	0.000405	CcSEcCtD
Duloxetine—Erythema—Triamcinolone—allergic rhinitis	6.54e-05	0.000403	CcSEcCtD
Duloxetine—Malnutrition—Methylprednisolone—allergic rhinitis	6.52e-05	0.000402	CcSEcCtD
Duloxetine—Erythema—Methylprednisolone—allergic rhinitis	6.52e-05	0.000402	CcSEcCtD
Duloxetine—Angioedema—Prednisolone—allergic rhinitis	6.5e-05	0.000401	CcSEcCtD
Duloxetine—Ill-defined disorder—Hydrocortisone—allergic rhinitis	6.44e-05	0.000397	CcSEcCtD
Duloxetine—Malaise—Prednisolone—allergic rhinitis	6.41e-05	0.000395	CcSEcCtD
Duloxetine—Dysgeusia—Triamcinolone—allergic rhinitis	6.4e-05	0.000395	CcSEcCtD
Duloxetine—Vertigo—Prednisolone—allergic rhinitis	6.39e-05	0.000394	CcSEcCtD
Duloxetine—Syncope—Prednisolone—allergic rhinitis	6.38e-05	0.000393	CcSEcCtD
Duloxetine—Eye disorder—Betamethasone—allergic rhinitis	6.37e-05	0.000393	CcSEcCtD
Duloxetine—Eye disorder—Dexamethasone—allergic rhinitis	6.37e-05	0.000393	CcSEcCtD
Duloxetine—Angioedema—Hydrocortisone—allergic rhinitis	6.34e-05	0.000391	CcSEcCtD
Duloxetine—Back pain—Triamcinolone—allergic rhinitis	6.32e-05	0.00039	CcSEcCtD
Duloxetine—Malaise—Hydrocortisone—allergic rhinitis	6.26e-05	0.000386	CcSEcCtD
Duloxetine—Loss of consciousness—Prednisolone—allergic rhinitis	6.25e-05	0.000385	CcSEcCtD
Duloxetine—Vertigo—Hydrocortisone—allergic rhinitis	6.24e-05	0.000385	CcSEcCtD
Duloxetine—Nausea—Montelukast—allergic rhinitis	6.23e-05	0.000384	CcSEcCtD
Duloxetine—Syncope—Hydrocortisone—allergic rhinitis	6.23e-05	0.000384	CcSEcCtD
Duloxetine—Angiopathy—Betamethasone—allergic rhinitis	6.18e-05	0.000381	CcSEcCtD
Duloxetine—Angiopathy—Dexamethasone—allergic rhinitis	6.18e-05	0.000381	CcSEcCtD
Duloxetine—Convulsion—Prednisolone—allergic rhinitis	6.16e-05	0.00038	CcSEcCtD
Duloxetine—Hypertension—Prednisolone—allergic rhinitis	6.14e-05	0.000379	CcSEcCtD
Duloxetine—Loss of consciousness—Hydrocortisone—allergic rhinitis	6.1e-05	0.000376	CcSEcCtD
Duloxetine—NPY1R—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	6.09e-05	0.0312	CbGpPWpGaD
Duloxetine—Arrhythmia—Dexamethasone—allergic rhinitis	6.09e-05	0.000375	CcSEcCtD
Duloxetine—Arrhythmia—Betamethasone—allergic rhinitis	6.09e-05	0.000375	CcSEcCtD
Duloxetine—Ill-defined disorder—Triamcinolone—allergic rhinitis	6.07e-05	0.000374	CcSEcCtD
Duloxetine—Ill-defined disorder—Methylprednisolone—allergic rhinitis	6.05e-05	0.000373	CcSEcCtD
Duloxetine—Alopecia—Betamethasone—allergic rhinitis	6.02e-05	0.000371	CcSEcCtD
Duloxetine—Alopecia—Dexamethasone—allergic rhinitis	6.02e-05	0.000371	CcSEcCtD
Duloxetine—Convulsion—Hydrocortisone—allergic rhinitis	6.02e-05	0.000371	CcSEcCtD
Duloxetine—Hypertension—Hydrocortisone—allergic rhinitis	5.99e-05	0.00037	CcSEcCtD
Duloxetine—Discomfort—Prednisolone—allergic rhinitis	5.98e-05	0.000369	CcSEcCtD
Duloxetine—Angioedema—Triamcinolone—allergic rhinitis	5.97e-05	0.000368	CcSEcCtD
Duloxetine—Angioedema—Methylprednisolone—allergic rhinitis	5.96e-05	0.000368	CcSEcCtD
Duloxetine—Erythema—Dexamethasone—allergic rhinitis	5.93e-05	0.000366	CcSEcCtD
Duloxetine—Erythema—Betamethasone—allergic rhinitis	5.93e-05	0.000366	CcSEcCtD
Duloxetine—Myalgia—Hydrocortisone—allergic rhinitis	5.91e-05	0.000365	CcSEcCtD
Duloxetine—Malaise—Triamcinolone—allergic rhinitis	5.9e-05	0.000364	CcSEcCtD
Duloxetine—Anxiety—Hydrocortisone—allergic rhinitis	5.89e-05	0.000363	CcSEcCtD
Duloxetine—Malaise—Methylprednisolone—allergic rhinitis	5.88e-05	0.000363	CcSEcCtD
Duloxetine—Vertigo—Triamcinolone—allergic rhinitis	5.87e-05	0.000362	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	5.87e-05	0.000362	CcSEcCtD
Duloxetine—Syncope—Triamcinolone—allergic rhinitis	5.86e-05	0.000362	CcSEcCtD
Duloxetine—Vertigo—Methylprednisolone—allergic rhinitis	5.86e-05	0.000361	CcSEcCtD
Duloxetine—Syncope—Methylprednisolone—allergic rhinitis	5.85e-05	0.000361	CcSEcCtD
Duloxetine—Discomfort—Hydrocortisone—allergic rhinitis	5.84e-05	0.00036	CcSEcCtD
Duloxetine—Anaphylactic shock—Prednisolone—allergic rhinitis	5.8e-05	0.000358	CcSEcCtD
Duloxetine—Oedema—Prednisolone—allergic rhinitis	5.8e-05	0.000358	CcSEcCtD
Duloxetine—Loss of consciousness—Triamcinolone—allergic rhinitis	5.75e-05	0.000354	CcSEcCtD
Duloxetine—Loss of consciousness—Methylprednisolone—allergic rhinitis	5.73e-05	0.000354	CcSEcCtD
Duloxetine—Shock—Prednisolone—allergic rhinitis	5.71e-05	0.000352	CcSEcCtD
Duloxetine—Cough—Triamcinolone—allergic rhinitis	5.7e-05	0.000352	CcSEcCtD
Duloxetine—Oedema—Hydrocortisone—allergic rhinitis	5.67e-05	0.00035	CcSEcCtD
Duloxetine—Anaphylactic shock—Hydrocortisone—allergic rhinitis	5.67e-05	0.00035	CcSEcCtD
Duloxetine—Convulsion—Triamcinolone—allergic rhinitis	5.66e-05	0.000349	CcSEcCtD
Duloxetine—Tachycardia—Prednisolone—allergic rhinitis	5.66e-05	0.000349	CcSEcCtD
Duloxetine—Convulsion—Methylprednisolone—allergic rhinitis	5.65e-05	0.000349	CcSEcCtD
Duloxetine—Hypertension—Triamcinolone—allergic rhinitis	5.64e-05	0.000348	CcSEcCtD
Duloxetine—Hypertension—Methylprednisolone—allergic rhinitis	5.63e-05	0.000347	CcSEcCtD
Duloxetine—Infection—Hydrocortisone—allergic rhinitis	5.63e-05	0.000347	CcSEcCtD
Duloxetine—Hyperhidrosis—Prednisolone—allergic rhinitis	5.61e-05	0.000346	CcSEcCtD
Duloxetine—Shock—Hydrocortisone—allergic rhinitis	5.57e-05	0.000344	CcSEcCtD
Duloxetine—Myalgia—Triamcinolone—allergic rhinitis	5.57e-05	0.000343	CcSEcCtD
Duloxetine—Nervous system disorder—Hydrocortisone—allergic rhinitis	5.56e-05	0.000343	CcSEcCtD
Duloxetine—Myalgia—Methylprednisolone—allergic rhinitis	5.55e-05	0.000343	CcSEcCtD
Duloxetine—Arthralgia—Methylprednisolone—allergic rhinitis	5.55e-05	0.000343	CcSEcCtD
Duloxetine—Anxiety—Methylprednisolone—allergic rhinitis	5.53e-05	0.000341	CcSEcCtD
Duloxetine—Tachycardia—Hydrocortisone—allergic rhinitis	5.53e-05	0.000341	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	5.52e-05	0.00034	CcSEcCtD
Duloxetine—Skin disorder—Hydrocortisone—allergic rhinitis	5.5e-05	0.000339	CcSEcCtD
Duloxetine—Ill-defined disorder—Betamethasone—allergic rhinitis	5.5e-05	0.000339	CcSEcCtD
Duloxetine—Ill-defined disorder—Dexamethasone—allergic rhinitis	5.5e-05	0.000339	CcSEcCtD
Duloxetine—Discomfort—Triamcinolone—allergic rhinitis	5.5e-05	0.000339	CcSEcCtD
Duloxetine—Discomfort—Methylprednisolone—allergic rhinitis	5.49e-05	0.000338	CcSEcCtD
Duloxetine—Hyperhidrosis—Hydrocortisone—allergic rhinitis	5.48e-05	0.000338	CcSEcCtD
Duloxetine—SLC6A2—autonomic nervous system—allergic rhinitis	5.47e-05	0.235	CbGeAlD
Duloxetine—NPY1R—Peptide ligand-binding receptors—TAC1—allergic rhinitis	5.46e-05	0.028	CbGpPWpGaD
Duloxetine—Dry mouth—Triamcinolone—allergic rhinitis	5.44e-05	0.000336	CcSEcCtD
Duloxetine—Angioedema—Dexamethasone—allergic rhinitis	5.42e-05	0.000334	CcSEcCtD
Duloxetine—Angioedema—Betamethasone—allergic rhinitis	5.42e-05	0.000334	CcSEcCtD
Duloxetine—Anorexia—Hydrocortisone—allergic rhinitis	5.4e-05	0.000333	CcSEcCtD
Duloxetine—Confusional state—Methylprednisolone—allergic rhinitis	5.37e-05	0.000331	CcSEcCtD
Duloxetine—Malaise—Betamethasone—allergic rhinitis	5.35e-05	0.00033	CcSEcCtD
Duloxetine—Malaise—Dexamethasone—allergic rhinitis	5.35e-05	0.00033	CcSEcCtD
Duloxetine—Anaphylactic shock—Triamcinolone—allergic rhinitis	5.34e-05	0.000329	CcSEcCtD
Duloxetine—Oedema—Triamcinolone—allergic rhinitis	5.34e-05	0.000329	CcSEcCtD
Duloxetine—Vertigo—Betamethasone—allergic rhinitis	5.33e-05	0.000329	CcSEcCtD
Duloxetine—Vertigo—Dexamethasone—allergic rhinitis	5.33e-05	0.000329	CcSEcCtD
Duloxetine—Anaphylactic shock—Methylprednisolone—allergic rhinitis	5.32e-05	0.000328	CcSEcCtD
Duloxetine—Syncope—Dexamethasone—allergic rhinitis	5.32e-05	0.000328	CcSEcCtD
Duloxetine—Syncope—Betamethasone—allergic rhinitis	5.32e-05	0.000328	CcSEcCtD
Duloxetine—Infection—Triamcinolone—allergic rhinitis	5.3e-05	0.000327	CcSEcCtD
Duloxetine—Infection—Methylprednisolone—allergic rhinitis	5.29e-05	0.000326	CcSEcCtD
Duloxetine—Shock—Triamcinolone—allergic rhinitis	5.25e-05	0.000324	CcSEcCtD
Duloxetine—Insomnia—Prednisolone—allergic rhinitis	5.25e-05	0.000324	CcSEcCtD
Duloxetine—Shock—Methylprednisolone—allergic rhinitis	5.24e-05	0.000323	CcSEcCtD
Duloxetine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	5.22e-05	0.0268	CbGpPWpGaD
Duloxetine—Nervous system disorder—Methylprednisolone—allergic rhinitis	5.22e-05	0.000322	CcSEcCtD
Duloxetine—Loss of consciousness—Betamethasone—allergic rhinitis	5.21e-05	0.000322	CcSEcCtD
Duloxetine—Loss of consciousness—Dexamethasone—allergic rhinitis	5.21e-05	0.000322	CcSEcCtD
Duloxetine—Paraesthesia—Prednisolone—allergic rhinitis	5.21e-05	0.000321	CcSEcCtD
Duloxetine—Tachycardia—Triamcinolone—allergic rhinitis	5.21e-05	0.000321	CcSEcCtD
Duloxetine—Tachycardia—Methylprednisolone—allergic rhinitis	5.2e-05	0.00032	CcSEcCtD
Duloxetine—Skin disorder—Methylprednisolone—allergic rhinitis	5.17e-05	0.000319	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	5.16e-05	0.000318	CcSEcCtD
Duloxetine—Hyperhidrosis—Triamcinolone—allergic rhinitis	5.16e-05	0.000318	CcSEcCtD
Duloxetine—Hyperhidrosis—Methylprednisolone—allergic rhinitis	5.15e-05	0.000317	CcSEcCtD
Duloxetine—Convulsion—Betamethasone—allergic rhinitis	5.14e-05	0.000317	CcSEcCtD
Duloxetine—Convulsion—Dexamethasone—allergic rhinitis	5.14e-05	0.000317	CcSEcCtD
Duloxetine—Insomnia—Hydrocortisone—allergic rhinitis	5.12e-05	0.000316	CcSEcCtD
Duloxetine—Hypertension—Dexamethasone—allergic rhinitis	5.12e-05	0.000316	CcSEcCtD
Duloxetine—Hypertension—Betamethasone—allergic rhinitis	5.12e-05	0.000316	CcSEcCtD
Duloxetine—Paraesthesia—Hydrocortisone—allergic rhinitis	5.09e-05	0.000314	CcSEcCtD
Duloxetine—NPY1R—GPCR ligand binding—PTGDR2—allergic rhinitis	5.07e-05	0.026	CbGpPWpGaD
Duloxetine—Myalgia—Dexamethasone—allergic rhinitis	5.05e-05	0.000311	CcSEcCtD
Duloxetine—Myalgia—Betamethasone—allergic rhinitis	5.05e-05	0.000311	CcSEcCtD
Duloxetine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	5.04e-05	0.0258	CbGpPWpGaD
Duloxetine—Anxiety—Betamethasone—allergic rhinitis	5.03e-05	0.00031	CcSEcCtD
Duloxetine—Anxiety—Dexamethasone—allergic rhinitis	5.03e-05	0.00031	CcSEcCtD
Duloxetine—Discomfort—Betamethasone—allergic rhinitis	4.99e-05	0.000308	CcSEcCtD
Duloxetine—Discomfort—Dexamethasone—allergic rhinitis	4.99e-05	0.000308	CcSEcCtD
Duloxetine—Dyspepsia—Hydrocortisone—allergic rhinitis	4.99e-05	0.000308	CcSEcCtD
Duloxetine—Pain—Prednisolone—allergic rhinitis	4.96e-05	0.000306	CcSEcCtD
Duloxetine—Decreased appetite—Hydrocortisone—allergic rhinitis	4.93e-05	0.000304	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	4.89e-05	0.000302	CcSEcCtD
Duloxetine—Fatigue—Hydrocortisone—allergic rhinitis	4.89e-05	0.000301	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	4.86e-05	0.0003	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	4.85e-05	0.000299	CcSEcCtD
Duloxetine—Pain—Hydrocortisone—allergic rhinitis	4.85e-05	0.000299	CcSEcCtD
Duloxetine—Oedema—Betamethasone—allergic rhinitis	4.84e-05	0.000299	CcSEcCtD
Duloxetine—Anaphylactic shock—Dexamethasone—allergic rhinitis	4.84e-05	0.000299	CcSEcCtD
Duloxetine—Anaphylactic shock—Betamethasone—allergic rhinitis	4.84e-05	0.000299	CcSEcCtD
Duloxetine—Oedema—Dexamethasone—allergic rhinitis	4.84e-05	0.000299	CcSEcCtD
Duloxetine—Insomnia—Triamcinolone—allergic rhinitis	4.83e-05	0.000298	CcSEcCtD
Duloxetine—Insomnia—Methylprednisolone—allergic rhinitis	4.81e-05	0.000297	CcSEcCtD
Duloxetine—Infection—Dexamethasone—allergic rhinitis	4.81e-05	0.000297	CcSEcCtD
Duloxetine—Infection—Betamethasone—allergic rhinitis	4.81e-05	0.000297	CcSEcCtD
Duloxetine—Paraesthesia—Triamcinolone—allergic rhinitis	4.79e-05	0.000296	CcSEcCtD
Duloxetine—Feeling abnormal—Prednisolone—allergic rhinitis	4.78e-05	0.000295	CcSEcCtD
Duloxetine—Paraesthesia—Methylprednisolone—allergic rhinitis	4.78e-05	0.000295	CcSEcCtD
Duloxetine—Shock—Dexamethasone—allergic rhinitis	4.76e-05	0.000294	CcSEcCtD
Duloxetine—Shock—Betamethasone—allergic rhinitis	4.76e-05	0.000294	CcSEcCtD
Duloxetine—Nervous system disorder—Dexamethasone—allergic rhinitis	4.75e-05	0.000293	CcSEcCtD
Duloxetine—Nervous system disorder—Betamethasone—allergic rhinitis	4.75e-05	0.000293	CcSEcCtD
Duloxetine—Thrombocytopenia—Dexamethasone—allergic rhinitis	4.74e-05	0.000292	CcSEcCtD
Duloxetine—Thrombocytopenia—Betamethasone—allergic rhinitis	4.74e-05	0.000292	CcSEcCtD
Duloxetine—Tachycardia—Betamethasone—allergic rhinitis	4.72e-05	0.000291	CcSEcCtD
Duloxetine—Tachycardia—Dexamethasone—allergic rhinitis	4.72e-05	0.000291	CcSEcCtD
Duloxetine—Dyspepsia—Triamcinolone—allergic rhinitis	4.7e-05	0.00029	CcSEcCtD
Duloxetine—Dyspepsia—Methylprednisolone—allergic rhinitis	4.69e-05	0.000289	CcSEcCtD
Duloxetine—Hyperhidrosis—Betamethasone—allergic rhinitis	4.68e-05	0.000289	CcSEcCtD
Duloxetine—Hyperhidrosis—Dexamethasone—allergic rhinitis	4.68e-05	0.000289	CcSEcCtD
Duloxetine—Feeling abnormal—Hydrocortisone—allergic rhinitis	4.67e-05	0.000288	CcSEcCtD
Duloxetine—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	4.63e-05	0.000286	CcSEcCtD
Duloxetine—Anorexia—Dexamethasone—allergic rhinitis	4.61e-05	0.000285	CcSEcCtD
Duloxetine—Anorexia—Betamethasone—allergic rhinitis	4.61e-05	0.000285	CcSEcCtD
Duloxetine—Urticaria—Prednisolone—allergic rhinitis	4.61e-05	0.000284	CcSEcCtD
Duloxetine—Fatigue—Triamcinolone—allergic rhinitis	4.6e-05	0.000284	CcSEcCtD
Duloxetine—Fatigue—Methylprednisolone—allergic rhinitis	4.59e-05	0.000283	CcSEcCtD
Duloxetine—Pain—Triamcinolone—allergic rhinitis	4.56e-05	0.000281	CcSEcCtD
Duloxetine—Urticaria—Hydrocortisone—allergic rhinitis	4.5e-05	0.000278	CcSEcCtD
Duloxetine—Body temperature increased—Hydrocortisone—allergic rhinitis	4.48e-05	0.000276	CcSEcCtD
Duloxetine—Abdominal pain—Hydrocortisone—allergic rhinitis	4.48e-05	0.000276	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	4.41e-05	0.000272	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	4.41e-05	0.000272	CcSEcCtD
Duloxetine—Feeling abnormal—Triamcinolone—allergic rhinitis	4.4e-05	0.000271	CcSEcCtD
Duloxetine—Feeling abnormal—Methylprednisolone—allergic rhinitis	4.39e-05	0.000271	CcSEcCtD
Duloxetine—Insomnia—Betamethasone—allergic rhinitis	4.38e-05	0.00027	CcSEcCtD
Duloxetine—Insomnia—Dexamethasone—allergic rhinitis	4.38e-05	0.00027	CcSEcCtD
Duloxetine—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	4.35e-05	0.000269	CcSEcCtD
Duloxetine—Paraesthesia—Dexamethasone—allergic rhinitis	4.35e-05	0.000268	CcSEcCtD
Duloxetine—Paraesthesia—Betamethasone—allergic rhinitis	4.35e-05	0.000268	CcSEcCtD
Duloxetine—Hypersensitivity—Prednisolone—allergic rhinitis	4.27e-05	0.000264	CcSEcCtD
Duloxetine—Dyspepsia—Dexamethasone—allergic rhinitis	4.26e-05	0.000263	CcSEcCtD
Duloxetine—Dyspepsia—Betamethasone—allergic rhinitis	4.26e-05	0.000263	CcSEcCtD
Duloxetine—Urticaria—Triamcinolone—allergic rhinitis	4.24e-05	0.000261	CcSEcCtD
Duloxetine—Urticaria—Methylprednisolone—allergic rhinitis	4.23e-05	0.000261	CcSEcCtD
Duloxetine—Body temperature increased—Triamcinolone—allergic rhinitis	4.22e-05	0.00026	CcSEcCtD
Duloxetine—Abdominal pain—Methylprednisolone—allergic rhinitis	4.21e-05	0.00026	CcSEcCtD
Duloxetine—Decreased appetite—Betamethasone—allergic rhinitis	4.21e-05	0.00026	CcSEcCtD
Duloxetine—Decreased appetite—Dexamethasone—allergic rhinitis	4.21e-05	0.00026	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	4.18e-05	0.000258	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Betamethasone—allergic rhinitis	4.18e-05	0.000258	CcSEcCtD
Duloxetine—Hypersensitivity—Hydrocortisone—allergic rhinitis	4.17e-05	0.000258	CcSEcCtD
Duloxetine—Fatigue—Dexamethasone—allergic rhinitis	4.17e-05	0.000257	CcSEcCtD
Duloxetine—Fatigue—Betamethasone—allergic rhinitis	4.17e-05	0.000257	CcSEcCtD
Duloxetine—Pain—Dexamethasone—allergic rhinitis	4.14e-05	0.000255	CcSEcCtD
Duloxetine—Pain—Betamethasone—allergic rhinitis	4.14e-05	0.000255	CcSEcCtD
Duloxetine—Asthenia—Hydrocortisone—allergic rhinitis	4.07e-05	0.000251	CcSEcCtD
Duloxetine—Pruritus—Hydrocortisone—allergic rhinitis	4.01e-05	0.000247	CcSEcCtD
Duloxetine—Feeling abnormal—Dexamethasone—allergic rhinitis	3.99e-05	0.000246	CcSEcCtD
Duloxetine—Feeling abnormal—Betamethasone—allergic rhinitis	3.99e-05	0.000246	CcSEcCtD
Duloxetine—NPY1R—GPCR ligand binding—CYSLTR1—allergic rhinitis	3.98e-05	0.0204	CbGpPWpGaD
Duloxetine—Gastrointestinal pain—Betamethasone—allergic rhinitis	3.96e-05	0.000244	CcSEcCtD
Duloxetine—Gastrointestinal pain—Dexamethasone—allergic rhinitis	3.96e-05	0.000244	CcSEcCtD
Duloxetine—Hypersensitivity—Triamcinolone—allergic rhinitis	3.93e-05	0.000242	CcSEcCtD
Duloxetine—Hypersensitivity—Methylprednisolone—allergic rhinitis	3.92e-05	0.000242	CcSEcCtD
Duloxetine—Diarrhoea—Hydrocortisone—allergic rhinitis	3.88e-05	0.000239	CcSEcCtD
Duloxetine—Urticaria—Dexamethasone—allergic rhinitis	3.85e-05	0.000237	CcSEcCtD
Duloxetine—Urticaria—Betamethasone—allergic rhinitis	3.85e-05	0.000237	CcSEcCtD
Duloxetine—NPY1R—GPCR ligand binding—CCL11—allergic rhinitis	3.84e-05	0.0197	CbGpPWpGaD
Duloxetine—Dizziness—Prednisolone—allergic rhinitis	3.84e-05	0.000237	CcSEcCtD
Duloxetine—Asthenia—Triamcinolone—allergic rhinitis	3.83e-05	0.000236	CcSEcCtD
Duloxetine—Abdominal pain—Betamethasone—allergic rhinitis	3.83e-05	0.000236	CcSEcCtD
Duloxetine—Body temperature increased—Dexamethasone—allergic rhinitis	3.83e-05	0.000236	CcSEcCtD
Duloxetine—Abdominal pain—Dexamethasone—allergic rhinitis	3.83e-05	0.000236	CcSEcCtD
Duloxetine—Body temperature increased—Betamethasone—allergic rhinitis	3.83e-05	0.000236	CcSEcCtD
Duloxetine—Asthenia—Methylprednisolone—allergic rhinitis	3.82e-05	0.000236	CcSEcCtD
Duloxetine—Pruritus—Triamcinolone—allergic rhinitis	3.77e-05	0.000233	CcSEcCtD
Duloxetine—Pruritus—Methylprednisolone—allergic rhinitis	3.77e-05	0.000232	CcSEcCtD
Duloxetine—Dizziness—Hydrocortisone—allergic rhinitis	3.75e-05	0.000231	CcSEcCtD
Duloxetine—NPY1R—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	3.66e-05	0.0188	CbGpPWpGaD
Duloxetine—Rash—Prednisolone—allergic rhinitis	3.66e-05	0.000226	CcSEcCtD
Duloxetine—Dermatitis—Prednisolone—allergic rhinitis	3.65e-05	0.000225	CcSEcCtD
Duloxetine—Diarrhoea—Methylprednisolone—allergic rhinitis	3.64e-05	0.000225	CcSEcCtD
Duloxetine—Headache—Prednisolone—allergic rhinitis	3.63e-05	0.000224	CcSEcCtD
Duloxetine—Vomiting—Hydrocortisone—allergic rhinitis	3.6e-05	0.000222	CcSEcCtD
Duloxetine—Rash—Hydrocortisone—allergic rhinitis	3.57e-05	0.00022	CcSEcCtD
Duloxetine—Dermatitis—Hydrocortisone—allergic rhinitis	3.57e-05	0.00022	CcSEcCtD
Duloxetine—Headache—Hydrocortisone—allergic rhinitis	3.55e-05	0.000219	CcSEcCtD
Duloxetine—Dizziness—Triamcinolone—allergic rhinitis	3.53e-05	0.000218	CcSEcCtD
Duloxetine—Dizziness—Methylprednisolone—allergic rhinitis	3.52e-05	0.000217	CcSEcCtD
Duloxetine—Asthenia—Betamethasone—allergic rhinitis	3.47e-05	0.000214	CcSEcCtD
Duloxetine—Asthenia—Dexamethasone—allergic rhinitis	3.47e-05	0.000214	CcSEcCtD
Duloxetine—Nausea—Prednisolone—allergic rhinitis	3.45e-05	0.000213	CcSEcCtD
Duloxetine—Pruritus—Dexamethasone—allergic rhinitis	3.43e-05	0.000211	CcSEcCtD
Duloxetine—Pruritus—Betamethasone—allergic rhinitis	3.43e-05	0.000211	CcSEcCtD
Duloxetine—Vomiting—Triamcinolone—allergic rhinitis	3.39e-05	0.000209	CcSEcCtD
Duloxetine—Vomiting—Methylprednisolone—allergic rhinitis	3.38e-05	0.000209	CcSEcCtD
Duloxetine—Nausea—Hydrocortisone—allergic rhinitis	3.37e-05	0.000208	CcSEcCtD
Duloxetine—Rash—Triamcinolone—allergic rhinitis	3.36e-05	0.000208	CcSEcCtD
Duloxetine—Dermatitis—Triamcinolone—allergic rhinitis	3.36e-05	0.000207	CcSEcCtD
Duloxetine—Rash—Methylprednisolone—allergic rhinitis	3.36e-05	0.000207	CcSEcCtD
Duloxetine—Dermatitis—Methylprednisolone—allergic rhinitis	3.35e-05	0.000207	CcSEcCtD
Duloxetine—Headache—Triamcinolone—allergic rhinitis	3.34e-05	0.000206	CcSEcCtD
Duloxetine—Headache—Methylprednisolone—allergic rhinitis	3.34e-05	0.000206	CcSEcCtD
Duloxetine—Diarrhoea—Dexamethasone—allergic rhinitis	3.31e-05	0.000204	CcSEcCtD
Duloxetine—Diarrhoea—Betamethasone—allergic rhinitis	3.31e-05	0.000204	CcSEcCtD
Duloxetine—HTR2A—autonomic nervous system—allergic rhinitis	3.29e-05	0.141	CbGeAlD
Duloxetine—Dizziness—Dexamethasone—allergic rhinitis	3.2e-05	0.000197	CcSEcCtD
Duloxetine—Dizziness—Betamethasone—allergic rhinitis	3.2e-05	0.000197	CcSEcCtD
Duloxetine—Nausea—Triamcinolone—allergic rhinitis	3.17e-05	0.000195	CcSEcCtD
Duloxetine—Nausea—Methylprednisolone—allergic rhinitis	3.16e-05	0.000195	CcSEcCtD
Duloxetine—Vomiting—Betamethasone—allergic rhinitis	3.08e-05	0.00019	CcSEcCtD
Duloxetine—Vomiting—Dexamethasone—allergic rhinitis	3.08e-05	0.00019	CcSEcCtD
Duloxetine—Rash—Dexamethasone—allergic rhinitis	3.05e-05	0.000188	CcSEcCtD
Duloxetine—Rash—Betamethasone—allergic rhinitis	3.05e-05	0.000188	CcSEcCtD
Duloxetine—Dermatitis—Betamethasone—allergic rhinitis	3.05e-05	0.000188	CcSEcCtD
Duloxetine—Dermatitis—Dexamethasone—allergic rhinitis	3.05e-05	0.000188	CcSEcCtD
Duloxetine—Headache—Betamethasone—allergic rhinitis	3.03e-05	0.000187	CcSEcCtD
Duloxetine—Headache—Dexamethasone—allergic rhinitis	3.03e-05	0.000187	CcSEcCtD
Duloxetine—Nausea—Dexamethasone—allergic rhinitis	2.88e-05	0.000177	CcSEcCtD
Duloxetine—Nausea—Betamethasone—allergic rhinitis	2.88e-05	0.000177	CcSEcCtD
Duloxetine—HTR6—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	2.86e-05	0.0147	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—PTGDR2—allergic rhinitis	2.86e-05	0.0147	CbGpPWpGaD
Duloxetine—NPY1R—GPCR ligand binding—TAC1—allergic rhinitis	2.79e-05	0.0143	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—IL13—allergic rhinitis	2.72e-05	0.014	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—PTGDR2—allergic rhinitis	2.6e-05	0.0133	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—TAC1—allergic rhinitis	2.51e-05	0.0128	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	2.45e-05	0.0126	CbGpPWpGaD
Duloxetine—HTR6—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	2.25e-05	0.0115	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—CYSLTR1—allergic rhinitis	2.25e-05	0.0115	CbGpPWpGaD
Duloxetine—NPY1R—lung—allergic rhinitis	2.2e-05	0.0945	CbGeAlD
Duloxetine—HTR2C—G alpha (q) signalling events—CYSLTR1—allergic rhinitis	2.14e-05	0.011	CbGpPWpGaD
Duloxetine—HTR2C—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	2.11e-05	0.0108	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—CYSLTR1—allergic rhinitis	2.04e-05	0.0105	CbGpPWpGaD
Duloxetine—SLC6A3—Dopaminergic Neurogenesis—TGFB1—allergic rhinitis	1.98e-05	0.0101	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—CCL11—allergic rhinitis	1.97e-05	0.0101	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	1.93e-05	0.00987	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	1.92e-05	0.00982	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—PTGDR2—allergic rhinitis	1.87e-05	0.00958	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	1.86e-05	0.00954	CbGpPWpGaD
Duloxetine—HTR2A—G alpha (q) signalling events—CYSLTR1—allergic rhinitis	1.86e-05	0.00953	CbGpPWpGaD
Duloxetine—SLC6A4—Circadian rythm related genes—ADIPOQ—allergic rhinitis	1.84e-05	0.00945	CbGpPWpGaD
Duloxetine—HTR2A—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	1.83e-05	0.00939	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	1.81e-05	0.00927	CbGpPWpGaD
Duloxetine—SLC6A3—respiratory system—allergic rhinitis	1.75e-05	0.0749	CbGeAlD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—IL10—allergic rhinitis	1.7e-05	0.00873	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	1.66e-05	0.00853	CbGpPWpGaD
Duloxetine—HTR2C—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	1.66e-05	0.00849	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—IL13—allergic rhinitis	1.64e-05	0.0084	CbGpPWpGaD
Duloxetine—SLC6A4—respiratory system—allergic rhinitis	1.6e-05	0.0686	CbGeAlD
Duloxetine—NPY1R—GPCR downstream signaling—TAC1—allergic rhinitis	1.58e-05	0.00808	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	1.57e-05	0.00805	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—PTGDR2—allergic rhinitis	1.54e-05	0.00787	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—TAC1—allergic rhinitis	1.51e-05	0.00773	CbGpPWpGaD
Duloxetine—HTR2C—G alpha (q) signalling events—TAC1—allergic rhinitis	1.5e-05	0.0077	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—CYSLTR1—allergic rhinitis	1.47e-05	0.00752	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—IL5—allergic rhinitis	1.47e-05	0.00751	CbGpPWpGaD
Duloxetine—HTR2A—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	1.44e-05	0.00737	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—TAC1—allergic rhinitis	1.43e-05	0.00734	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	1.42e-05	0.00727	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—CCL11—allergic rhinitis	1.42e-05	0.00726	CbGpPWpGaD
Duloxetine—SLC6A2—respiratory system—allergic rhinitis	1.41e-05	0.0604	CbGeAlD
Duloxetine—HTR2C—GPCR ligand binding—PTGDR2—allergic rhinitis	1.38e-05	0.00706	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	1.37e-05	0.00702	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	1.35e-05	0.00693	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	1.34e-05	0.00689	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—IL5—allergic rhinitis	1.33e-05	0.00682	CbGpPWpGaD
Duloxetine—HTR2A—G alpha (q) signalling events—TAC1—allergic rhinitis	1.31e-05	0.00669	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	1.23e-05	0.00631	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CYSLTR1—allergic rhinitis	1.21e-05	0.00618	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—PTGDR2—allergic rhinitis	1.2e-05	0.00613	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	1.19e-05	0.0061	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	1.17e-05	0.00598	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CCL11—allergic rhinitis	1.16e-05	0.00597	CbGpPWpGaD
Duloxetine—CYP2D6—Melatonin metabolism and effects—NFKB1—allergic rhinitis	1.14e-05	0.00586	CbGpPWpGaD
Duloxetine—CYP1A2—respiratory system—allergic rhinitis	1.08e-05	0.0465	CbGeAlD
Duloxetine—HTR2C—GPCR ligand binding—CYSLTR1—allergic rhinitis	1.08e-05	0.00554	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—PTGDR2—allergic rhinitis	1.06e-05	0.00541	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CCL11—allergic rhinitis	1.04e-05	0.00535	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—TAC1—allergic rhinitis	1.03e-05	0.00528	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—IL10—allergic rhinitis	1.03e-05	0.00526	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	9.95e-06	0.0051	CbGpPWpGaD
Duloxetine—CYP1A2—Melatonin metabolism and effects—NFKB1—allergic rhinitis	9.68e-06	0.00496	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—PTGDR2—allergic rhinitis	9.59e-06	0.00492	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CYSLTR1—allergic rhinitis	9.38e-06	0.00481	CbGpPWpGaD
Duloxetine—SLC6A3—lung—allergic rhinitis	9.27e-06	0.0398	CbGeAlD
Duloxetine—HTR2A—GPCR ligand binding—CCL11—allergic rhinitis	9.06e-06	0.00464	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	8.64e-06	0.00443	CbGpPWpGaD
Duloxetine—SLC6A4—lung—allergic rhinitis	8.49e-06	0.0364	CbGeAlD
Duloxetine—HTR2A—respiratory system—allergic rhinitis	8.46e-06	0.0363	CbGeAlD
Duloxetine—NPY1R—Signaling Pathways—TAC1—allergic rhinitis	8.46e-06	0.00434	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	8.34e-06	0.00427	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CYSLTR1—allergic rhinitis	8.29e-06	0.00425	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—IL5—allergic rhinitis	7.86e-06	0.00403	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—PTGDR2—allergic rhinitis	7.78e-06	0.00399	CbGpPWpGaD
Duloxetine—HTR2A—eye—allergic rhinitis	7.73e-06	0.0332	CbGeAlD
Duloxetine—HTR2C—GPCR ligand binding—TAC1—allergic rhinitis	7.58e-06	0.00389	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CYSLTR1—allergic rhinitis	7.53e-06	0.00386	CbGpPWpGaD
Duloxetine—SLC6A2—lung—allergic rhinitis	7.48e-06	0.0321	CbGeAlD
Duloxetine—SLC6A4—NRF2 pathway—TGFB1—allergic rhinitis	7.32e-06	0.00375	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CCL11—allergic rhinitis	7.27e-06	0.00373	CbGpPWpGaD
Duloxetine—HTR2A—epithelium—allergic rhinitis	7.07e-06	0.0304	CbGeAlD
Duloxetine—HTR2C—Signaling by GPCR—PTGDR2—allergic rhinitis	7.06e-06	0.00362	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—PTGDR2—allergic rhinitis	6.76e-06	0.00346	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	6.69e-06	0.00343	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—TAC1—allergic rhinitis	6.58e-06	0.00337	CbGpPWpGaD
Duloxetine—SLC6A2—NRF2 pathway—TGFB1—allergic rhinitis	6.3e-06	0.00323	CbGpPWpGaD
Duloxetine—HTR2A—trachea—allergic rhinitis	6.25e-06	0.0268	CbGeAlD
Duloxetine—HTR2A—Signaling by GPCR—PTGDR2—allergic rhinitis	6.13e-06	0.00314	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CYSLTR1—allergic rhinitis	6.1e-06	0.00313	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—TAC1—allergic rhinitis	5.82e-06	0.00298	CbGpPWpGaD
Duloxetine—CYP1A2—lung—allergic rhinitis	5.75e-06	0.0247	CbGeAlD
Duloxetine—HTR6—Signaling Pathways—PTGDR2—allergic rhinitis	5.67e-06	0.0029	CbGpPWpGaD
Duloxetine—SLC6A3—NRF2 pathway—TGFB1—allergic rhinitis	5.58e-06	0.00286	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	5.58e-06	0.00286	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CYSLTR1—allergic rhinitis	5.54e-06	0.00284	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—SMAD3—allergic rhinitis	5.53e-06	0.00284	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—IL5—allergic rhinitis	5.41e-06	0.00277	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CCL11—allergic rhinitis	5.35e-06	0.00274	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	5.3e-06	0.00272	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—TAC1—allergic rhinitis	5.28e-06	0.00271	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	5.02e-06	0.00257	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—IL5—allergic rhinitis	4.91e-06	0.00252	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CYSLTR1—allergic rhinitis	4.81e-06	0.00247	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CCL11—allergic rhinitis	4.65e-06	0.00238	CbGpPWpGaD
Duloxetine—HTR2A—lung—allergic rhinitis	4.49e-06	0.0193	CbGeAlD
Duloxetine—HTR6—Signaling Pathways—CYSLTR1—allergic rhinitis	4.45e-06	0.00228	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCL11—allergic rhinitis	4.29e-06	0.0022	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—TAC1—allergic rhinitis	4.28e-06	0.0022	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—PTGDR2—allergic rhinitis	4.17e-06	0.00214	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—IL5—allergic rhinitis	3.98e-06	0.00204	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—TAC1—allergic rhinitis	3.89e-06	0.00199	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—TAC1—allergic rhinitis	3.72e-06	0.00191	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—PTGDR2—allergic rhinitis	3.62e-06	0.00186	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—IL5—allergic rhinitis	3.62e-06	0.00185	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—IL5—allergic rhinitis	3.46e-06	0.00177	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—TAC1—allergic rhinitis	3.38e-06	0.00173	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CYSLTR1—allergic rhinitis	3.27e-06	0.00168	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCL11—allergic rhinitis	3.16e-06	0.00162	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—IL5—allergic rhinitis	3.14e-06	0.00161	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—TAC1—allergic rhinitis	3.12e-06	0.0016	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—IL5—allergic rhinitis	2.9e-06	0.00149	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CYSLTR1—allergic rhinitis	2.84e-06	0.00146	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—NFKB1—allergic rhinitis	2.81e-06	0.00144	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCL11—allergic rhinitis	2.75e-06	0.00141	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—TGFB1—allergic rhinitis	2.34e-06	0.0012	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—TAC1—allergic rhinitis	2.3e-06	0.00118	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IL5—allergic rhinitis	2.14e-06	0.00109	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—SMAD3—allergic rhinitis	2.04e-06	0.00105	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—TAC1—allergic rhinitis	2e-06	0.00102	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IL5—allergic rhinitis	1.86e-06	0.000951	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—SMAD3—allergic rhinitis	1.5e-06	0.000771	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—SMAD3—allergic rhinitis	1.31e-06	0.000669	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NFKB1—allergic rhinitis	1.04e-06	0.000532	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—TGFB1—allergic rhinitis	8.64e-07	0.000443	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NFKB1—allergic rhinitis	7.64e-07	0.000392	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NFKB1—allergic rhinitis	6.64e-07	0.00034	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—TGFB1—allergic rhinitis	6.37e-07	0.000326	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—TGFB1—allergic rhinitis	5.53e-07	0.000283	CbGpPWpGaD
